Targeting SHP2 Cryptic Allosteric Sites for Effective Cancer Therapy
International Journal of Molecular Sciences · 2024
DOI: 10.3390/ijms25116201 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2024. Verfasst von Ashfaq Ur Rehman und 4 weiteren Autor:innen. Beteiligte Einrichtung: Departments of Molecular Biology and Biochemistry, Chemical and Biomolecular Engineering, Materials Science and Engineering, and Biomedical Engineeri…. Hauptthemen laut MEDLINE: Neoplasms, Protein Tyrosine Phosphatase, Non-Receptor Type 11. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 56 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIGMS NIH HHS, NIH HHS, NIH/NIGMS.
Abstract (Originalsprache)
SHP2, a pivotal component downstream of both receptor and non-receptor tyrosine kinases, has been underscored in the progression of various human cancers and neurodevelopmental disorders. Allosteric inhibitors have been proposed to regulate its autoinhibition. However, oncogenic mutations, such as E76K, convert SHP2 into its open state, wherein the catalytic cleft becomes fully exposed to its ligands. This study elucidates the dynamic properties of SHP2 structures across different states, with a focus on the effects of oncogenic mutation on two known binding sites of allosteric inhibitors. Through extensive modeling and simulations, we further identified an alternative allosteric binding pocket in solution structures. Additional analysis provides insights into the dynamics and stability of the potential site. In addition, multi-tier screening was deployed to identify potential binders targeting the potential site. Our efforts to identify a new allosteric site contribute to community-wide initiatives developing therapies using multiple allosteric inhibitors to target distinct pockets on SHP2, in the hope of potentially inhibiting or slowing tumor growth associated with SHP2.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Departments of Molecular Biology and Biochemistry, Chemical and Biomolecular Engineering, Materials Science and Engineering, and Biomedical Engineering, University of California, Irvine, CA 92697, USA.
ORCID-Profile: Ashfaq Ur Rehman, Cizhang Zhao, Ray Luo
Förderung
- NIGMS NIH HHS
- NIH HHS
- NIH/NIGMS
Zitieren
APA
Rehman, A. U., Zhao, C., Wu, Y., Zhu, Q., & Luo, R. (2024). Targeting SHP2 Cryptic Allosteric Sites for Effective Cancer Therapy. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms25116201
Vancouver
Rehman AU, Zhao C, Wu Y, Zhu Q, Luo R. Targeting SHP2 Cryptic Allosteric Sites for Effective Cancer Therapy. International Journal of Molecular Sciences. 2024. doi:10.3390/ijms25116201
BibTeX
@article{Rehman2024,
author = {Rehman, Ashfaq Ur and Zhao, Cizhang and Wu, Yongxian and Zhu, Qiang and Luo, Ray},
title = {Targeting SHP2 Cryptic Allosteric Sites for Effective Cancer Therapy},
journal = {International Journal of Molecular Sciences},
year = {2024},
doi = {10.3390/ijms25116201}
}
EUVIMED